{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:11:37Z","timestamp":1790068297890,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.canlet.2017.04.019","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T22:47:13Z","timestamp":1493074033000},"page":"110-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma"],"prefix":"10.1016","volume":"400","author":[{"given":"Hiroaki","family":"Miyahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridevi","family":"Yadavilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Natsumeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Rubens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Kambhampati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Asnaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-7037","authenticated-orcid":false,"given":"Eric H.","family":"Raabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2017.04.019_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fonc.2012.00205","article-title":"Diffuse intrinsic pontine glioma: poised for progress","volume":"2","author":"Warren","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2017.04.019_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00401-014-1319-6","article-title":"Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications","volume":"128","author":"Buczkowicz","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.canlet.2017.04.019_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1309\/AJCPABOHBC33FVMO","article-title":"H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas","volume":"139","author":"Gielen","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.canlet.2017.04.019_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00412-015-0510-4","article-title":"Histone H3 mutations-a special role for H3.3 in tumorigenesis?","volume":"124","author":"Kallappagoudar","year":"2015","journal-title":"Chromosoma"},{"key":"10.1016\/j.canlet.2017.04.019_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.canlet.2017.04.019_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-015-0269-0","article-title":"Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics","volume":"4","author":"Hoffman","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.canlet.2017.04.019_bib7","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.1038\/ncomms11185","article-title":"Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma","volume":"7","author":"Nikbakht","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2017.04.019_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2017.04.019_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/neuonc\/nor190","article-title":"Genomic aberrations in pediatric diffuse intrinsic pontine gliomas","volume":"14","author":"Warren","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2017.04.019_bib10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","article-title":"Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets","volume":"28","author":"Zarghooni","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.canlet.2017.04.019_bib11","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00381-015-2832-1","article-title":"Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas","volume":"31","author":"Puget","year":"2015","journal-title":"Child's Nerv. Syst. ChNS Official J. Int. Soc. Pediatr. Neurosurg."},{"key":"10.1016\/j.canlet.2017.04.019_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2017.04.019_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ni.2867","article-title":"The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex","volume":"15","author":"Heikamp","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2017.04.019_bib14","doi-asserted-by":"crossref","first-page":"14963","DOI":"10.1074\/jbc.M114.627794","article-title":"Target of rapamycin complex 2 regulates actin polarization and endocytosis via multiple pathways","volume":"290","author":"Rispal","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2017.04.019_bib15","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2174\/092986711796391651","article-title":"ATP-competitive inhibitors of mTOR: an update","volume":"18","author":"Schenone","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.canlet.2017.04.019_bib16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2017.04.019_bib17","doi-asserted-by":"crossref","first-page":"pe24","DOI":"10.1126\/scisignal.267pe24","article-title":"The pharmacology of mTOR inhibition","volume":"2","author":"Guertin","year":"2009","journal-title":"Sci. Signal"},{"key":"10.1016\/j.canlet.2017.04.019_bib18","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.18632\/oncotarget.2337","article-title":"Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors","volume":"5","author":"Hassan","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.04.019_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Hsieh","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2017.04.019_bib20","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1158\/1078-0432.CCR-11-2750","article-title":"Dual mTORC1\/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy","volume":"18","author":"Garcia-Garcia","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.04.019_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1158\/1535-7163.MCT-14-0711","article-title":"MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in\u00a0vitro and in\u00a0vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma","volume":"14","author":"Slotkin","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2017.04.019_bib22","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbrc.2014.06.081","article-title":"The novel mTORC1\/2 dual inhibitor INK-128 suppresses survival and proliferation of primary and transformed human pancreatic cancer cells","volume":"450","author":"Lou","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.04.019_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10495-014-1066-0","article-title":"mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling","volume":"20","author":"Zhang","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2017.04.019_bib24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10549-012-2298-8","article-title":"Investigational drug MLN0128, a novel TORC1\/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models","volume":"136","author":"Gokmen-Polar","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2017.04.019_bib25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/NEN.0000000000000216","article-title":"Disrupting NOTCH slows diffuse intrinsic pontine glioma growth, enhances radiation sensitivity, and shows combinatorial efficacy with bromodomain inhibition","volume":"74","author":"Taylor","year":"2015","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.canlet.2017.04.019_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11060-012-0973-6","article-title":"Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment","volume":"110","author":"Hashizume","year":"2012","journal-title":"J.\u00a0Neurooncol"},{"key":"10.1016\/j.canlet.2017.04.019_bib27","doi-asserted-by":"crossref","first-page":"e0118926","DOI":"10.1371\/journal.pone.0118926","article-title":"A\u00a0high-throughput in\u00a0vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent","volume":"10","author":"Halvorson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2017.04.019_bib28","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/neuonc\/not132","article-title":"Activation of mTORC1\/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target","volume":"15","author":"Hutt-Cabezas","year":"2013","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2017.04.019_bib29","series-title":"ImageJ","author":"Rasband","year":"1997"},{"key":"10.1016\/j.canlet.2017.04.019_bib30","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.18632\/oncotarget.1131","article-title":"LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program","volume":"4","author":"Mao","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.04.019_bib31","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.18632\/oncotarget.3078","article-title":"Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target","volume":"6","author":"Weingart","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.04.019_bib32","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-10-3349","article-title":"BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model","volume":"17","author":"Raabe","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.04.019_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-14-17","article-title":"Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases","volume":"14","author":"Choi","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2017.04.019_bib34","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1158\/1535-7163.MCT-14-0708","article-title":"Radiosensitization of primary human glioblastoma stem-like cells with low-dose AKT inhibition","volume":"14","author":"Mehta","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2017.04.019_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3892\/ijo.2013.1970","article-title":"Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines","volume":"43","author":"Millet","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2017.04.019_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/NEN.0000000000000161","article-title":"The chromatin-modifying protein HMGA2 promotes atypical teratoid\/rhabdoid cell tumorigenicity","volume":"74","author":"Kaur","year":"2015","journal-title":"J.\u00a0Neuropathol Exp. Neurol"},{"key":"10.1016\/j.canlet.2017.04.019_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.canlet.2016.04.020","article-title":"The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma","volume":"377","author":"Kaur","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.04.019_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1158\/1541-7786.MCR-11-0457","article-title":"Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in\u00a0vivo","author":"Kaur","year":"2012","journal-title":"Mol. Cancer Res.: MCR 10"},{"key":"10.1016\/j.canlet.2017.04.019_bib39","doi-asserted-by":"crossref","first-page":"12141","DOI":"10.18632\/oncotarget.3716","article-title":"The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma","volume":"6","author":"Yadavilli","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.04.019_bib40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/1087057110361772","article-title":"A\u00a0simplified method for quantifying cell migration\/wound healing in 96-well plates","volume":"15","author":"Yue","year":"2010","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.canlet.2017.04.019_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2005.06.007","article-title":"An expanding role for mTOR in cancer","volume":"11","author":"Guertin","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2017.04.019_bib42","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1021\/jf100718b","article-title":"Polyphenol-rich extracts from Solanum nigrum attenuated PKC alpha-mediated migration and invasion of hepatocellular carcinoma cells","volume":"58","author":"Yang","year":"2010","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.canlet.2017.04.019_bib43","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3892\/or.2015.4027","article-title":"Aurora kinases are essential for PKC-induced invasion and matrix metalloproteinase-9 expression in MCF-7 breast cancer cells","volume":"34","author":"Noh","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.04.019_bib44","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.yexcr.2009.04.009","article-title":"Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC\/MEK\/ERK and PKC\/PI3K\/Akt pathways","volume":"315","author":"Matsuoka","year":"2009","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2017.04.019_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3892\/or.2015.3972","article-title":"P2Y2 nucleotide receptor-mediated extracellular signal-regulated kinases and protein kinase C activation induces the invasion of highly metastatic breast cancer cells","volume":"34","author":"Eun","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.04.019_bib46","doi-asserted-by":"crossref","first-page":"e0122179","DOI":"10.1371\/journal.pone.0122179","article-title":"Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC\/claudin-1-mediated signaling","volume":"10","author":"Hou","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2017.04.019_bib47","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/pbc.24989","article-title":"Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing program","volume":"61","author":"Kang","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2017.04.019_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12964-015-0091-0","article-title":"Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma","volume":"13","author":"Mazan-Mamczarz","year":"2015","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.canlet.2017.04.019_bib49","doi-asserted-by":"crossref","first-page":"11712","DOI":"10.1158\/0008-5472.CAN-07-2223","article-title":"mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor","volume":"67","author":"Masri","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.04.019_bib50","doi-asserted-by":"crossref","first-page":"10339","DOI":"10.1038\/srep10339","article-title":"Target of rapamycin complex 2 regulates cell growth via Myc in Drosophila","volume":"5","author":"Kuo","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517302793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517302793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T16:21:12Z","timestamp":1569082872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383517302793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":50,"alternative-id":["S0304383517302793"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2017.04.019","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2017.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}